Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 13, 2022
Daily Cannabis Use Is a Barrier to Tobacco Cessation Among Tobacco Quitline Callers at 7-Month Follow-upRenee D Goodwin, Alina Shevorykin, Ellen Carl, et al.Neurological Research|June 20, 2012
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosisClive B Beggs, Simon J Shepherd, Michael G Dwyer, et al.Therapeutic Advances in Neurological Disorders|May 6, 2015
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosisRobert Zivadinov, Michael Dwyer, Silva Markovic-Plese, et al.Plos One|December 6, 2011
Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteersKresimir Dolic, Bianca Weinstock-Guttman, Karen Marr, et al.Journal of the Neurological Sciences|January 16, 2014
Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndromeRoberto Cappellani, Niels Bergsland, Bianca Weinstock-Guttman, et al.Neurological Research|September 14, 2012
Heart disease, overweight, and cigarette smoking are associated with increased prevalence of extra-cranial venous abnormalitiesKresimir Dolic, Bianca Weinstock-Guttman, Karen Marr, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2016
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivationBianca Weinstock-Guttman, Jesper Hagemeier, Katelyn S Kavak, et al.Journal of Clinical Medicine|March 16, 2019
Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot StudyRobert Zivadinov, Niels Bergsland, Ellen Carl, et al.Journal of Neuroimmunology|April 14, 2015
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weeklyMichael G Dwyer, Robert Zivadinov, Silva Markovic-Plese, et al.Radiology|April 25, 2013
Thalamic atrophy is associated with development of clinically definite multiple sclerosisRobert Zivadinov, Eva Havrdová, Niels Bergsland, et al.Pageof 6